Global Multivalent Vaccines Market Research Report 2019

Table of Contents

Executive Summary

1 Multivalent Vaccines Market Overview

• 1.1 Product Overview and Scope of Multivalent Vaccines
• 1.2 Multivalent Vaccines Segment by Type
  • 1.2.1 Global Multivalent Vaccines Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Conjugate Vaccines
  • 1.2.3 Inactivated and Subunit Vaccines
  • 1.2.4 Live Attenuated Vaccines
  • 1.2.5 Toxoid Vaccines
  • 1.2.6 Recombinant Vaccines
• 1.3 Multivalent Vaccines Segment by Application
  • 1.3.1 Multivalent Vaccines Consumption Comparison by Application (2014-2025)
  • 1.3.2 Pediatrics
  • 1.3.3 Adults
• 1.3 Global Multivalent Vaccines Market by Region
  • 1.3.1 Global Multivalent Vaccines Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Multivalent Vaccines Market Size
  • 1.4.1 Global Multivalent Vaccines Revenue (2014-2025)
  • 1.4.2 Global Multivalent Vaccines Production (2014-2025)

2 Global Multivalent Vaccines Market Competition by Manufacturers

• 2.1 Global Multivalent Vaccines Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Multivalent Vaccines Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Multivalent Vaccines Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Multivalent Vaccines Production Sites, Area Served, Product Types
• 2.5 Multivalent Vaccines Market Competitive Situation and Trends
  • 2.5.1 Multivalent Vaccines Market Concentration Rate
  • 2.5.2 Multivalent Vaccines Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Multivalent Vaccines Production Market Share by Regions

• 3.1 Global Multivalent Vaccines Production Market Share by Regions
• 3.2 Global Multivalent Vaccines Revenue Market Share by Regions (2014-2019)
• 3.3 Global Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Multivalent Vaccines Production
  • 3.4.1 North America Multivalent Vaccines Production Growth Rate (2014-2019)
  • 3.4.2 North America Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Multivalent Vaccines Production
  • 3.5.1 Europe Multivalent Vaccines Production Growth Rate (2014-2019)
  • 3.5.2 Europe Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Multivalent Vaccines Production (2014-2019)
  • 3.6.1 China Multivalent Vaccines Production Growth Rate (2014-2019)
  • 3.6.2 China Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Multivalent Vaccines Production (2014-2019)
  • 3.7.1 Japan Multivalent Vaccines Production Growth Rate (2014-2019)
  • 3.7.2 Japan Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Multivalent Vaccines Consumption by Regions

• 4.1 Global Multivalent Vaccines Consumption by Regions
• 4.2 North America Multivalent Vaccines Consumption (2014-2019)
• 4.3 Europe Multivalent Vaccines Consumption (2014-2019)
• 4.4 China Multivalent Vaccines Consumption (2014-2019)
• 4.5 Japan Multivalent Vaccines Consumption (2014-2019)

5 Global Multivalent Vaccines Production, Revenue, Price Trend by Type

• 5.1 Global Multivalent Vaccines Production Market Share by Type (2014-2019)
• 5.2 Global Multivalent Vaccines Revenue Market Share by Type (2014-2019)
• 5.3 Global Multivalent Vaccines Price by Type (2014-2019)
• 5.4 Global Multivalent Vaccines Production Growth by Type (2014-2019)

6 Global Multivalent Vaccines Market Analysis by Applications

• 6.1 Global Multivalent Vaccines Consumption Market Share by Application (2014-2019)
• 6.2 Global Multivalent Vaccines Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Multivalent Vaccines Business

• 7.1 GlaxoSmithKline, plc (U.K.)
  • 7.1.1 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Production Sites and Area Served
  • 7.1.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.1.3 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Pfizer, Inc. (U.S.)
  • 7.2.1 Pfizer, Inc. (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 7.2.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.2.3 Pfizer, Inc. (U.S.) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Merck & Co., Inc. (U.S.)
  • 7.3.1 Merck & Co., Inc. (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 7.3.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.3.3 Merck & Co., Inc. (U.S.) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Sanofi Pasteur SA (France)
  • 7.4.1 Sanofi Pasteur SA (France) Multivalent Vaccines Production Sites and Area Served
  • 7.4.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.4.3 Sanofi Pasteur SA (France) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Astellas Pharma Inc. (Japan)
  • 7.5.1 Astellas Pharma Inc. (Japan) Multivalent Vaccines Production Sites and Area Served
  • 7.5.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.5.3 Astellas Pharma Inc. (Japan) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 CSL Limited (Australia)
  • 7.6.1 CSL Limited (Australia) Multivalent Vaccines Production Sites and Area Served
  • 7.6.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.6.3 CSL Limited (Australia) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Emergent BioSolutions, Inc. (U.S.)
  • 7.7.1 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 7.7.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.7.3 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Johnson & Johnson (U.S.)
  • 7.8.1 Johnson & Johnson (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 7.8.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.8.3 Johnson & Johnson (U.S.) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 MedImmune, LLC (U.S.)
  • 7.9.1 MedImmune, LLC (U.S.) Multivalent Vaccines Production Sites and Area Served
  • 7.9.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.9.3 MedImmune, LLC (U.S.) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Serum Institute of India Pvt. Ltd. (India)
  • 7.10.1 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Production Sites and Area Served
  • 7.10.2 Multivalent Vaccines Product Introduction, Application and Specification
  • 7.10.3 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Bavarian Nordic (Denmark)
• 7.12 Mitsubishi Tanabe Pharma Corporation (Japan)
• 7.13 Daiichi Sankyo (Japan)
• 7.14 Protein Sciences Corporation (U.S.)
• 7.15 Panacea Biotec (India)

8 Multivalent Vaccines Manufacturing Cost Analysis

• 8.1 Multivalent Vaccines Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Multivalent Vaccines
• 8.4 Multivalent Vaccines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Multivalent Vaccines Distributors List
• 9.3 Multivalent Vaccines Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Multivalent Vaccines Market Forecast

• 11.1 Global Multivalent Vaccines Production, Revenue Forecast
  • 11.1.1 Global Multivalent Vaccines Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Multivalent Vaccines Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Multivalent Vaccines Price and Trend Forecast (2019-2025)
• 11.2 Global Multivalent Vaccines Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Multivalent Vaccines Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Multivalent Vaccines Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Multivalent Vaccines Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Multivalent Vaccines Production, Revenue Forecast (2019-2025)
• 11.3 Global Multivalent Vaccines Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Multivalent Vaccines Consumption Forecast (2019-2025)
  • 11.3.2 Europe Multivalent Vaccines Consumption Forecast (2019-2025)
  • 11.3.3 China Multivalent Vaccines Consumption Forecast (2019-2025)
  • 11.3.4 Japan Multivalent Vaccines Consumption Forecast (2019-2025)
• 11.4 Global Multivalent Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Multivalent Vaccines Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List